Device & safety information
Regulatory status, intended use and safety information for the SmartHeart® 12-lead ECG device.
Last updated
Warning. The use of SmartHeart® does not substitute for a medical emergency service. If you think a patient is experiencing a medical emergency or crisis, contact your local emergency services immediately.
Caution. Read the User Guide carefully and entirely before using SmartHeart®. A thorough understanding of its operation is required for correct and accurate ECG transmission. Federal law restricts this device to sale by or on the order of a physician. An ECG should always be forwarded for review by a qualified physician.
FDA clearance
| 510(k) number | K113514 (510(k) summary, PDF) |
|---|---|
| Cleared | February 22, 2012 |
| Manufacturer | SHL Telemedicine International Ltd. |
| Classification | Telephone electrocardiograph transmitter and receiver, Class II, product code DXH, 21 CFR 870.2920 |
| Use | Prescription use (21 CFR 801 Subpart D) |
| Standards cited | IEC 60601-2-51:2005; IEC 60601-2-25 (1993) +A1:1999 |
Indications for use
“The Smartheart device is intended to condition an electrocardiographic signal so that it can be transmitted digitally via Bluetooth technology and cell-phone or communication device to a remote location. The Smartheart device is designed to be used by a patient to transmit a 12 lead ECG and rhythm strip in real-time to enable review at a physician’s office, hospital or other medical receiving center.”
FDA 510(k) K113514, Indications for Use Statement
What SmartHeart® is, and is not
- It records and transmits a resting 12-lead ECG with a rhythm strip.
- It is not a continuous or intra-operative monitor.
- The preliminary review supports, and does not replace, the clinician’s judgment. Cardiologist interpretation is a separate, on-request service.
- It does not substitute for emergency services.
Power
Runs on AAA lithium batteries, with the capability to produce about 100 ECGs before the batteries need changing.